Cross-AAPs acceleration of genomics for escalating infectious diseases
Year of award: 2024
Grantholders
Le Van Tan
Oxford Clinical Research Unit - Vietnam, Vietnam
Dr Anuraj Shankar
University of Oxford, United Kingdom
Dr Muki Shey
University of Cape Town, South Africa
Prof Lynette Isabella Oyier
Kemri-Wellcome Trust Research Programme, Kenya
Prof Lynette Isabella Oyier
Kemri-Wellcome Trust Research Programme, Kenya
Anne Amulele
Kemri-Wellcome Trust Research Programme, Kenya
Dr Elizabeth Batty
University of Oxford, United Kingdom
Dr Duy Pham
Oxford Clinical Research Unit - Vietnam, Vietnam
Dr Narisara Chantratita
Mahidol University, Thailand
Dr Juthathip Mongkolsapaya
University of Oxford, United Kingdom
Dr Raph Hamers
University of Oxford, United Kingdom
Dr Jennifer Cornick
University of Liverpool, United Kingdom
Prof Marvin HSIAO
National Health Laboratory Service, South Africa
Dr Alexander Sigal
Africa Health Research Institute, South Africa
Dr Audrey Dubot-Pérès
Institut de Recherche pour le Developpement, France
Project summary
Throughout the COVID-19 pandemic, the Africa Asia Programmes (AAPs), AHRI, KWTRP, MLW, MORU and OUCRU, and CIDRI-Africa (Discovery Platform), played a crucial role supporting Ministries of Health with diagnostics, genomic surveillance and real-time data to guide decision-making. We propose to now apply these established capacities to pathogens with an escalating infection burden in Africa and Southeast Asia, driven by climate change or the emergence of drug resistance, and for which there is a dearth of genomics data across Africa and Southeast Asia limiting effective action. The selected pathogens are: 1) the vector-borne dengue and chikungunya viruses; 2) multidrug-resistant Klebsiella pneumoniae; and 3) Mycobacterium tuberculosis. The proposed project will harmonise resources for archived and prospective sample collection and surveillance, whole-genome and targeted next-generation sequencing, metagenomics, bioinformatics, and the interoperability of genomic data and metadata across sites via the HL7 Fast Healthcare Interoperability Resources data standard. We aim to determine the national and international spread of these infections to inform national policy strategies for arboviruses control and antibiotic stewardship. The project will be managed via shared governance and oversight, enabling active engagement of the multidisciplinary teams with policy stakeholders across eight countries to accelerate translation of our findings to practice.